News

• Gencom Extends Capabilities To Include Genotoxicity Degradation Modeling

  Irvine CA USA February 14, 2008 Gencom announced today that the Company has extended the capabilities of its Genesys In-Silico Drug Discovery Optimization platform to include Genotoxic degradation modeling. Genotoxicity testing is commonly carried Read More posted Saturday, February 23, 2008 4:34 PM by Gencom | 0 Comments Filed Under: News

• Gencom Publishes Fact Sheet On Its Genesys In-Silico Drug Discovery Optimization Platform

  Genesys is a science-focused technology platform whose sole objective is to advance the discovery of human therapeutics. It was designed to optimize the entire drug discovery process; from target identification and elimination to in-silico forced degradation Read More posted Saturday, February 23, 2008 4:27 PM by Gencom | 0 Comments Filed Under: News Attachment(s): fact_sheet_genesys.pdf

• Gencom Recognized For Humanitarian Impact

  Leading Innovator in the Field of Drug Discovery Optimization Recognized By Itanium Solutions Alliance For Novel Development on the Itanium 2 Processor.     Beijing, CN – April 17, 2007 – The Itanium® Solutions Alliance (www.ItaniumSolutionsAlliance.org) Read More posted Sunday, April 22, 2007 6:56 PM by Gencom | 0 Comments Filed Under: News

• Gencom Takes Leading Role in Promoting "Genetic Bill of Rights"

  Leading Innovator in the Field of Drug Discovery Optimization Voices Opposition to Gene Patenting. Irvine, CA USA - January 26, 2007 - Gencom (www.GenomicComputation.com) announced today that the Company has taken a position in the contentious debate Read More posted Friday, January 26, 2007 8:03 PM by Gencom | 0 Comments Filed Under: News

Case Studies

Presentations, Podcasts, Webcasts

White Papers

Reference Links